Ontology highlight
ABSTRACT:
SUBMITTER: Somi MH
PROVIDER: S-EPMC7539312 | biostudies-literature | 2020 Sep
REPOSITORIES: biostudies-literature
Somi Mohammad Hossein MH Sepehri Bita B Sepehri Bita B Nikniaz Zeinab Z Sedghi Roya R
Advanced pharmaceutical bulletin 20200809 4
<b><i>Purpose:</i></b> Sofosbuvir (SOF) and daclatasvir (DOC) are suggested for the treatment of hepatitis C virus (HCV) in patients with concomitant HCV and human immunodeficiency virus (HIV). In 2016, Sovodak tablet a combination of SOF and DOC was introduced. In the present study we assessed the effectiveness of SOF in the treatment of HCV in patients co-infected with HIV. <b><i>Methods:</i></b> A total of 26 HCV patients co-infected with HIV received SOF for 3 months. One patient did not adh ...[more]